Thalidomide
Chemical Structure Depiction of
Thalidomide
Thalidomide
Compound characteristics
| Compound ID: | CE01-0254 |
| Compound Name: | Thalidomide |
| Molecular Weight: | 258.23 |
| Molecular Formula: | C13 H10 N2 O4 |
| CAS Number: | 50-35-1 |
| Smiles: | C1CC(NC(C1N1C(c2ccccc2C1=O)=O)=O)=O |
| InChI Key: | UEJJHQNACJXSKW-VIFPVBQESA-N |
| Short Description: | Thalidomide (Thalomid) is a synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties. |
| Pathway: | PROTAC|||Apoptosis|||Autophagy |
| Target: | Apoptosis|||Autophagy|||Ligand for E3 Ligase|||TNF|||Molecular Glues |
| Type of molecule: | FDA Approved/Clinical |
| Alias: | Sedoval , Thalomid |
| Stock amount: | 25252 |